How Slick Consulting Firms Get Us On Drugs
Ninety-one people a day die from opioids and 1,000 visit ERs in the US, according to the CDC. How did opioid makers get such a deathly grip on the US population? Recently, the New York Times reported that the global consulting firm McKinsey & Company had a big hand in these morbid figures.
McKinsey advised Purdue Pharma to “turbocharge” OxyContin sales and use mail orders to bypass pharmacy scrutiny claims a Massachusetts lawsuit against the drug maker. Another state lawsuit accuses McKinsey of advising an opioid maker to “get more patients on higher doses of opioids” and study techniques “for keeping patients on opioids longer.” We all know what happened.
Purdue Pharma also deliberately marketed OxyContin as a 12-hour med—providing pain relief for 12 hours, and only requiring a twice-a-day dose—though documents show that Purdue and its sales reps knew that was a lie, the Los Angeles Times reported.